AUROBINDO PHARMA is a leading global Pharmaceutical company with over 27 years of experience. The company's robust product portfolio is spread over six major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The company is marketing these products globally, in over 125 countries. A well-integrated pharma company, Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator